In a world where biotech startups obsess over SEO and social media, ONCOtracker is playing a different game entirely. With zero monthly website visits and a team of just six, they're betting everything on one brutal niche: multiple myeloma.

"They're not building a platform—they're building a precision weapon for one disease."

• Tech stack reveals ambition: WordPress for speed, React for future scalability, Bootstrap for rapid prototyping
• Social presence is minimal but strategic—LinkedIn and Twitter suggest B2B focus, not consumer outreach
• The 'bcma' keyword is their only SEO footprint, indicating they're not optimizing for discovery but for precision
• Contact page exists, but no public emails—likely relying on warm introductions and industry networks

The absence of traffic isn't a failure—it's a feature. ONCOtracker isn't building a brand for the masses; they're building credibility within the oncology ecosystem. Their website serves as a digital business card for investors, partners, and researchers who already know where to look. The real question isn't why they have zero traffic, but what they're building that requires such deliberate invisibility.